2024 Controlled & Modified Drug Release Summit
May 14-15, 2024
Princeton Marriott at Forrestal, Princeton, NJ
Main Conference Day One – Wednesday, 5th October, 2022
7:45am
9:00am
Collaboration is King! Ice Breaker
9:10am
9:15am
Innovative Gastro-Retentive & Chronotherapeutic Drug Delivery Technologies for Challenging Compounds

Dipen Desai, PhD
Vice President, Complex Product Development
Amneal Pharmaceuticals
9:50am
Model-Guided Formulation Design to Improve Therapeutic Index

Arijit Chakravarty, PhD
Chief Executive Officer
Fractal Therapeutics
10:25am
Bioavailability-Enhancing Formulations to Rapidly Bring Poorly Soluble Compounds to the Clinic

Santipharp Panmai, PhD
Vice President and Head of Early-phase Formulation Development
WuXi STA
10:50am
11:20am
Long-Acting Injectables – Biopharmaceutics and Drug Product Design

Pratik Saha, PhD
Director, Biopharmaceutics, Pharmaceutical Development
GlaxoSmithKline
11:55am
PANEL DISCUSSION: Enhancing Bioavailability via Patient-Centric Formulation Approaches

Deb Das, PhD
Senior Associate Director & Science Fellow
Bayer

Manuel Sanchez-Felix, PhD
Senior Fellow, Novel Delivery Technologies
Novartis Institute for Biomedical Research

Dipen Desai, PhD
Vice President, Complex Product Development
Amneal Pharmaceuticals

Pratik Saha, PhD
Director, Biopharmaceutics, Pharmaceutical Development
GlaxoSmithKline
12:40pm
![[660x330] 8e615b9d 2851 4cf4 9e08 Cdc8ff186532](http://curtiscoulter.com/wp-content/uploads/2022/08/660x330-8e615b9d-2851-4cf4-9e08-cdc8ff186532.png)
![[660x330] Ce4eb283 Af10 4dd9 B3c3 F8e7ccf80242](http://curtiscoulter.com/wp-content/uploads/2022/08/660x330-ce4eb283-af10-4dd9-b3c3-f8e7ccf80242.png)
2:00pm
Exploring Opportunities for Sustained Release Long-Acting Injectables and Implantables: Translation to Commercialization

Morgan Giles, PhD
Associate Principal Scientist, Sterile & Specialty Products
Merck
Subcutaneous Delivery Market Trends and Challenges

Manuel Sanchez-Felix, PhD
Senior Fellow, Novel Delivery Technologies
Novartis Institute for Biomedical Research
2:35pm
Long-Acting PLGA Injectables: Market, Modalities, and Opportunities

Nathan Dormer, PhD
Director, Drug Product Development
Adare Pharma Solutions
In Vitro Screening Tools for the Selection of Membrane-Permeable Peptides

Iriny Ekladious, PhD
Associate Principal Scientist, Sterile and Specialty Products
Merck & Co.
3:10pm
Afternoon Networking & Refreshment Break in Exhibit Hall
3:40pm
Rational Design of Oral Formulation to Improve Bioavailability of Weak-Base Compounds

Jiayling (Ingrid) Liu, PhD
Senior Scientist, Oral Formulation Sciences
Merck & Co.
IVIVC on Ready-to-Use SEDDS Using Pion Macroflux

Nitin Swarnakar, PhD
NA Pharma Applications Manager
BASF
4:20pm
Spray Conjealing to Enhance Drug Product Bioavailability

Arul Joseph, PhD
Senior Director, CMC Pharmaceutical Development
Otsuka Pharmaceuticals
5:00pm-
6:00pm
Main Conference Day Two – Thursday, October 6th, 2022
8:00am
9:00am
9:10am
Literature Analysis of Subcutaneous Bioavailability Prediction from In-Vitro Model Data

Mikhail Murashov, PhD
Senior Scientist, Sterile and Specialty Products
Merck & Co.
9:50am
Achieving a Sustained Release Profile in Drug Discovery

Wenzhan Yang, PhD
Project Lead/Pharmaceutical Development
AstraZeneca
10:30am
Morning Networking & Refreshment Break
11:00am
Overcoming Bioavailability Challenges of Peptide-Based Drug Product Development

Saji Vijayan, PhD
Chief Scientific Officer & Vice President, Global Translational and Pharmaceutical Sciences
Endo Pharmaceuticals
11:30am
Long-Acting Injectables via Nanosuspension for Improving Bioavailability

Ramesh Palaparthy, PhD
Executive Director, Clinical Pharmacology
Gilead Sciences
11:55am
Engineering Bisphosphonate Lipid-Like Materials for mRNA Delivery

Lulu Xie, PhD
Postdoctoral Research Associate, Prof. Mitchell Lab
University of Pennsylvania
12:30pm
Networking Lunch
1:45pm
MED 3D Printing for Oral Bioavailability Enhancement

Xiaoling Li, PhD
Professor, Thomas J Long School of Pharmacy, University of the Pacific and CSO
Triastek
2:20pm
Advances in Ocular Delivery: Examining Multiple Drug Modalities and Pre-Clinical Models

Gillie Roth, PhD
Scientist, Preclinical and Translational PKPD
Genentech
2:55pm
Using Modeling to Design Better Sustained Release Formulations

Arijit Chakravarty, PhD
Chief Executive Officer
Fractal Therapeutics
3:30pm
Chair’s Closing & 2022 Summit Concludes
Attend
Meet 120+ drug development professionals & learn over 2 YEARS worth of new product development strategies, formulation approaches, delivery technologies & regulatory updates while decreasing drug product time-to-market in just 3 days!
Sponsorship
Take advantage of the unique opportunity to engage your direct target audience face-to-face, and help them overcome their product challenges in 2 full interactive days!